Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oncolytics Biotech Inc. ONCY

Set alert

Price alert · ONCY

All alert types
0.39 USD -0.01 -2.33%

As of Nov 3, 1:51 PM ET

Bid
0.39 × 1
Ask
0.39 × 5
0.39 Day range 0.4072
0.39 52-week range 1.30
YTD
-55.09%
1 year
-64.16%
Open
0.40
Prev close
0.40
Mkt cap
51.23M
Vol
348.52K
Avg vol
1.04M
EPS
-0.35
P/E
0.00
Div yield
0.00%
More statistics
Low
0.39
High
0.4072
Forward P/E
-3.02
Beta
1.51
Short ratio
3.51
Inst. own
1.76%
Dividend
0.00
Ex-div date
50-d avg
1.04
200-d avg
1.04
1y target
4.85

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 3, 2023Earnings: -0.1; estimate -0.07; surprise -42.86%
  • Mar 7, 2024Earnings: -0.04; estimate -0.11; surprise 63.64%
  • Apr 4, 2024Rating: Raymond James · — → Outperform
  • Aug 1, 2024Earnings: -0.07; estimate -0.08; surprise 12.5%
Signals (87)
NameDateAgo
MACD: Sell SignalSep 1, 20262 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BullishFeb 1, 20269 months ago
SMA: BullishJan 1, 202610 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BearishOct 1, 20251 year ago
SMA: BullishSep 1, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
SMA: BullishJun 1, 20251 year ago
SMA: BearishNov 1, 20242 years ago
SMA: BullishOct 1, 20242 years ago
MACD: Sell SignalJan 1, 20242 years ago
SMA: BearishOct 1, 20233 years ago
SMA: BearishOct 1, 20233 years ago
SMA: BullishJun 1, 20233 years ago
SMA: BullishApr 1, 20233 years ago
SMA: BearishMar 1, 20233 years ago

Newest 20 of 87.

Financial health

Altman Z-Score

-95.51 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.9×
FY 2016: -2.2×FY 2017: -6.0×FY 2018: -2.3×FY 2019: -4.1×FY 2020: -6.3×FY 2021: -3.6×FY 2022: -5.0×FY 2023: -4.3×FY 2024: -4.4×FY 2025: -2.9×
FY 2016 5y median -4.3× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -22.1×
FY 2016: 3.2×FY 2017: 11.3×FY 2018: 6.4×FY 2019: -1267×FY 2020: 4.9×FY 2021: 2.6×FY 2022: 4.8×FY 2023: 4.3×FY 2024: 16.8×FY 2025: -22.1×
FY 2016 5y median 4.3× FY 2025
P/FCF -5.7×
FY 2016: -2.7×FY 2017: -6.2×FY 2018: -3.3×FY 2019: -6.9×FY 2020: -5.5×FY 2021: -4.1×FY 2022: -7.4×FY 2023: -5.5×FY 2024: -5.0×FY 2025: -5.7×
FY 2016 5y median -5.5× FY 2025
EV/EBITDA -3.8×
FY 2016: -1.6×FY 2017: -5.5×FY 2018: -1.5×FY 2019: -6.3×FY 2020: -3.7×FY 2021: -2.1×FY 2022: -6.0×FY 2023: -3.3×FY 2024: -3.4×FY 2025: -3.8×
FY 2016 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -17.5%
FY 2016: -36.9%FY 2017: -16.1%FY 2018: -30.4%FY 2019: -14.6%FY 2020: -18.0%FY 2021: -24.2%FY 2022: -13.5%FY 2023: -18.2%FY 2024: -20.0%FY 2025: -17.5%
FY 2016 5y median -18.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 551.7%
FY 2016: -141.6%FY 2017: -188.5%FY 2018: -275.0%FY 2019: 42219.6%FY 2020: -90.9%FY 2021: -72.9%FY 2022: -69.0%FY 2023: -75.9%FY 2024: -381.0%FY 2025: 551.7%
FY 2016 5y median -72.9% FY 2025
ROIC -1250.6%
FY 2016: -143.1%FY 2017: -120.8%FY 2018: -138.3%FY 2019: -282.6%FY 2020: -79.8%FY 2021: -60.3%FY 2022: -59.0%FY 2023: -73.4%FY 2024: -185.4%FY 2025: -1250.6%
FY 2016 5y median -73.4% FY 2025
ROA -276.4%
FY 2016: -102.6%FY 2017: -86.0%FY 2018: -114.6%FY 2019: -231.7%FY 2020: -65.5%FY 2021: -57.3%FY 2022: -49.0%FY 2023: -53.9%FY 2024: -112.9%FY 2025: -276.4%
FY 2016 5y median -57.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -12.5%
FY 2016: -9.9%FY 2017: -2.0%FY 2018: -6.8%FY 2019: -20.9%FY 2020: -26.4%FY 2021: -3.0%FY 2022: 24.4%FY 2023: -28.4%FY 2024: -0.3%FY 2025: -12.5%
FY 2016 FY 2025
EPS (diluted) -36.7%
FY 2016: -3.4%FY 2017: 6.7%FY 2018: 5.4%FY 2019: -41.5%FY 2020: 68.0%FY 2021: -2.1%FY 2022: 10.2%FY 2023: 6.8%FY 2024: 26.8%FY 2025: -36.7%
FY 2016 FY 2025
Free Cash Flow -0.3%
FY 2016: 17.4%FY 2017: -20.0%FY 2018: 19.8%FY 2019: -65.6%FY 2020: -10.9%FY 2021: -2.8%FY 2022: 24.1%FY 2023: -24.4%FY 2024: 6.5%FY 2025: -0.3%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 3.5×FY 2017: 3.4×FY 2018: 5.1×FY 2019: 1.5×FY 2020: 12.5×FY 2021: 16.7×FY 2022: 9.0×FY 2023: 9.0×FY 2024: 2.8×FY 2025: 1.1×
FY 2016 5y median 9.0× FY 2025
Quick Ratio 1.1×
FY 2016: 3.5×FY 2017: 3.4×FY 2018: 5.1×FY 2019: 1.5×FY 2020: 12.5×FY 2021: 16.7×FY 2022: 9.0×FY 2023: 9.0×FY 2024: 2.8×FY 2025: 1.1×
FY 2016 5y median 9.0× FY 2025
Debt / Equity -0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -4.7×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.2×FY 2025: -0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.9×FY 2017: 0.8×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 1.2×FY 2021: 1.6×FY 2022: 0.6×FY 2023: 1.4×FY 2024: 0.6×FY 2025: 0.2×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31